Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery 
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement 
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools 
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy 
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates 
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz 
Robinhood Expands Sports Event Contracts With Player Performance Wagers 
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report 
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change 
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate 
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand 
Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push 
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand 
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy 
OpenAI Explores Massive Funding Round at $750 Billion Valuation 
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy 
 Market Report 2016 - Analysis & Forecasts 2009-2020 - EconoTimes)
Dublin, Dec. 22, 2016 -- Research and Markets has announced the addition of the "Global Market Report On 2,4-Dihydroxy-3,5-Dibromopyridine 2016" report to their offering.
The Global Market Report on 2,4-Dihydroxy-3,5-Dibromopyridine provides comprehensive data on 2,4-Dihydroxy-3,5-Dibromopyridine global and regional markets including Europe, Asia, North America, Latin America
The report captures 2,4-Dihydroxy-3,5-Dibromopyridine market trends and pays close attention to 2,4-Dihydroxy-3,5-Dibromopyridine.
The report is broken into three main parts including manufacturing methods & technology development, market landscape & trend analysis, and distribution policy.
In the manufacturing methods & technology development section, the main manufacturing methods of 2,4-Dihydroxy-3,5-Dibromopyridine are introduced.
Key Topics Covered:
Part 1: Introduction of 2,4-Dihydroxy-3,5-Dibromopyridine
Chapter 1: Brief Introduction of 2,4-Dihydroxy-3,5-Dibromopyridine
Chapter 2: Product Identification
Chapter 3: Physical Properties
Chapter 4: Quality Specifications
Part 2: Manufacture Methods and Technology Development of 2,4-Dihydroxy-3,5-Dibromopyridine
Chapter 1: Introduction of Main Manufacture Methods
Chapter 2: Introduction of Patent Manufacture Methods
Chapter 3: New Progress on the Manufacture Technology
Part 3: Application of 2,4-Dihydroxy-3,5-Dibromopyridine
Chapter 1: Application Review
Chapter 2: End Products(Downstream Products) of 2,4-Dihydroxy-3,5-Dibromopyridine
Chapter 3: New Applications of 2,4-Dihydroxy-3,5-Dibromopyridine
Part 4: Production Situation of 2,4-Dihydroxy-3,5-Dibromopyridine
Chapter 1: Current Production Situation
Chapter 2: Manufacturers in China
Chapter 3: Manufacturers Outside of China
Chapter 4: Production Trend Analysis
Part 5: Market Situation of 2,4-Dihydroxy-3,5-Dibromopyridine
Chapter 1: Market Supply Status and Trend Forecast
Chapter 2: Downstream Consumer Market Analysis
Chapter 3: Supply and Demand Analysis and Forecast
Chapter 4: Price Analysis
Chapter 5: Import & Export Situation
Part 6: Distribution Policy of 2,4-Dihydroxy-3,5-Dibromopyridine
Chapter 1: Market Size in Major Use Segments
Chapter 2: Major End Users
Chapter 3: Potential Users
Part 7: References
For more information about this report visit http://www.researchandmarkets.com/research/8xjw42/global_market
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Chemicals
